Oramed Pharmaceuticals (ORMP) 10-Q2023 Q3 Quarterly report

Filed: 9 Nov 23, 5:10pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: Acquiom, Agency, assume, assumed, assuming, Assumption, attacked, attend, beneficial, beneficially, bifurcating, capped, Chairperson, complexity, curve, debt, debtor, declared, difficulty, disclosed, discretion, domestic, doubt, Dr, drawn, earlier, embedded, exemption, exit, floor, fluctuating, forfeited, forfeiture, greater, Henry, indirect, Issuer, Jaisim, Ji, led, lent, listed, mandatory, mentioned, multiplied, ORMP, owed, par, Penny, premium, prepayment, Promissory, release, repaid, repay, repayment, resale, scenario, Shah, SOFR, Specimen, subscription, sum, thereon, uncured, underlying, unpaid, valuation, Voluntary, war

Removed: achieve, adequate, administration, comprised, dependent, FDA, February, Food, foreign, implement, incur, internationally, licensing, occurrence, royalty, selling, TLA, transition

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ORMP similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350

In connection with the quarterly report of Oramed Pharmaceuticals Inc., or the Company, on Form 10-Q for the period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof, or the Report, I, Nadav Kidron, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, that to my knowledge:

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 9, 2023	By:	/s/ Nadav Kidron
		Nadav Kidron
		President and Chief Executive Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.